Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Reports Initial Offering in Uncle Bud’s New Premium Collection Sees ‘Enthusiastic Customer Response’

Pressure BioSciences (OTCQB: PBIO) and its wholly owned subsidiary, Uncle Bud’s, are reporting significant sales of it its revolutionary nanoemulsified CBD product: CBD Body Revive Spray; the spray has 1,200 mg of Nano-CBD. CBD Body Revive Spray is the initial product in Uncle Bud’s Premium Collection, which has been an immediate success. The Premium Collection includes UltraShear(TM) processed nanoemulsion products. PBIO’s patented UltraShear Technology(TM) allows oil-soluble active molecules such as vitamin D3, retinol and CBD to be prepared into high-quality nanoemulsions that offer rapid absorption and unparalleled bioavailability of the oil-based active ingredients into the water-based biochemistry of humans, animals and plants. PBIO is a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly enabling, pressure-based instruments and nanoemulsion products and services for the health and wellness, food and beverage, nutraceutical, cosmeceutical and other industries. In addition, the company announced that has received a Massachusetts processing license for industrial hemp, which allows PBIO to develop, manufacture, market and sell UltraShear Technology(TM)-processed products in the rapidly expanding CBD marketplace. “Uncle Bud’s newly launched Nano-CBD Body Revive Spray, an innovative, all-plant-based, organic, highly bioavailable flagship product processed using PBIO’s UltraShear platform, captured an impressive 30% conversion of Uncle Bud’s total CBD Revive Spray product revenue in March alone,” said Pressure BioSciencesdirector of sales and marketing John Hollister in the press release. “The surge in demand for this revolutionary new product prompted an urgent restocking of this initial product in Uncle Bud’s Premium Collection, in order to meet the enthusiastic consumer response to date.”

To view the full press release, visit https://ibn.fm/vpncl

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. The company’s patented, scalable and high-efficiency pressure-based UltraShear Technology(TM) platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. PBIO’s patented, original enabling platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counterbioterrorism applications. The company’s patented BaroFold(TM) technology platform positions PBIO to provide valuable contract services and GMP manufacturing equipment to the biopharmaceuticals industry. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.